Risk and Handling Precautions Risk Tier: MODERATE This rating reflects both peptides' bioactive activity at angiogenic and cytoskeletal signaling pathways in preclinical models, the absence of established human safety profiles for either compound, and the additional handling considerations specific to intranasal formulations
Buy Me a Coffee to say thanks, or become a paid subscriber and get subscriber-perks such as asking me about anything Musculoskeletal pain and injury in the Substack chat
Most physicians recommend introducing one compound before the other rather than starting both simultaneously
Rizvi F, Preston CC, Emelyanova L, Yousufuddin M, Viqar M, Dakwar O, et al
In addition, push out a tiny amount of solution to ensure there is no air left in the metal tip